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ABSTRACT
Post-translational histone modifications and chro-
matin remodelling play a critical role controlling the
integrity of the genome. Here, we identify histone ly-
sine demethylase PHF2 as a novel regulator of the
DNA damage response by regulating DNA damage-
induced focus formation of 53BP1 and BRCA1, crit-
ical factors in the pathway choice for DNA double
strand break repair. PHF2 knockdown leads to im-
paired BRCA1 focus formation and delays the res-
olution of 53BP1 foci. Moreover, irradiation-induced
RPA phosphorylation and focus formation, as well
as localization of CtIP, required for DNA end resec-
tion, to sites of DNA lesions are affected by deple-
tion of PHF2. These results are indicative of a defec-
tive resection of double strand breaks and thereby
an impaired homologous recombination upon PHF2
depletion. In accordance with these data, Rad51 fo-
cus formation and homology-directed double strand
break repair is inhibited in cells depleted for PHF2.
Importantly, we demonstrate that PHF2 knockdown
decreases CtIP and BRCA1 protein and mRNA lev-
els, an effect that is dependent on the demethylase
activity of PHF2. Furthermore, PHF2-depleted cells
display genome instability and are mildly sensitive to
the inhibition of PARP. Together these results demon-
strate that PHF2 promotes DNA repair by homolo-
gous recombination by controlling CtIP-dependent
resection of double strand breaks.
INTRODUCTION
The DNA damage response (DDR), which detects, signals
and repairs DNA lesions, is essential in the maintenance
of genome integrity and functions as a first defence in the
early stages of cancer development (1). Among the different
types of DNA lesions, DNA double strand breaks (DSBs)
are particularly hazardous to the cell as, if not repaired ade-
quately, they can lead to chromosomal rearrangements (2).
Mammalian cells have developed different pathways to
repair DSBs. Non-homologous end joining (NHEJ) is a
fast, and efficient, but also error-prone pathway in which
the broken DNA-ends are directly ligated. On the other
hand, during homologous recombination (HR), the sister
chromatid is used as a repair template and thereby results
in more accurate repair. Finally, the less efficient alterna-
tive non-homologous end joining (Alt-NHEJ), also called
microhomology-mediated end joining (MMEJ), uses short
microhomologous sequences during the alignment of bro-
ken ends (3). Several factors are important in DSB repair
pathway choice, in which the availability of homologous se-
quence, and therefore the cell cycle stage, plays a critical
role. Two DDR proteins that have an important influence
on this decision are 53BP1 and BRCA1, that together con-
trol DNA end resection, the degradation of theDNA end in
the 5′ to 3′ direction, resulting in singe-stranded (ss) DNA
that is critical for DSB repair by HR (4). Whereas 53BP1,
together with its partner RIF1 and the Shieldin complex
(5,6), blocks DNA end-resection and thus stimulates repair
through NHEJ, BRCA1 promotes DNA end-resection and
the removal of 53BP1 from sites of DNA damage, thereby
switching repair from NHEJ to HR (7,8). DNA end resec-
tion is initiated by endonuclease CtIP, in cooperation with
the Mre11/Rad50/Nbs1 (MRN) complex, and thereafter
extended by the EXO1 and DNA2 nucleases (9). The re-
sulting ssDNA is protected by immediate coating with the
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RPA1-3 complex, which is replaced by the Rad51 protein
that then mediates strand invasion (10).
Efficient DNA repair requires the correct and timely co-
ordination of amultitude of signalling events, inwhich post-
translational modifications play a critical role. As DNA le-
sions occur and are repaired in the context of chromatin,
it is not surprising that chromatin modifications impact on
this process (11). One of the earliest modifications upon
the induction of a DSB is the phosphorylation of his-
tone H2AX at serine 139 (named H2AX) by the cen-
tral DDR kinase ATM, on either side of the lesion (12).
H2AX phosphorylation triggers the initiation of protein
ubiquitination by the RNF8 E3 ubiquitin ligase, which is
recruited to DSBs via binding to MDC1, a direct reader of
H2AX (13). Ubiquitination of histones and other proteins
by RNF8 and RNF168, another E3 ligase that is subse-
quently bound, serves to recruit additional proteins, among
which are 53BP1 and BRCA1 (14,15). Also, the modifica-
tion of histone and non-histone proteins by methylation
and acetylation are involved in the regulation of DNA re-
pair. For example, the recruitment of 53BP1 depends on the
methylation of H4K20, the RNF8-dependent degradation
of competing H4K20me readers, deacetylation of H4K16
and RNF168-mediated H2AK15 ubiquitination (16). In
addition to promoting the direct recruitment of repair pro-
teins, chromatin modifications can physically facilitate the
accessibility of regulatory proteins to the lesion. An exam-
ple is lysine acetylation, which opens up the chromatin (17).
Finally, histone methylation regulates gene expression, by
recruiting proteins involved in this process or by inhibiting
the binding of transcription factors to DNA. Lysine methy-
lation of histone H3 and H4 is associated to both transcrip-
tional activation and repression, depending on the methy-
lation site (18).
Interestingly, defects in the regulation of chromatin mod-
ifying enzymes were described to be linked to genome in-
stability and tumour development (19). Here, we identified
PHD Finger Protein 2 (PHF2), also known as KDM7C
or JHDM1E, member of the KDM7 family of histone
demethylases, in a search for additional chromatin modi-
fications and regulators involved in DNA repair. PHF2 was
described as a transcriptional activator by demethylating
H3K9me2, although PHF2 was also shown to demethylate
H4K20me3, another transcriptional repression mark, and
suggested to demethylate non-histone proteins (20–23). Our
results show that PHF2 regulates the resection of DSBs by
controlling the levels of CtIP and BRCA1. By demonstrat-
ing that PHF2 regulates DNA DSB repair in this way, we
identify a novel function for this lysine-specific demethylase.
MATERIALS AND METHODS
Cell culture and treatments
293T, U2OS and HeLa cells were grown in DMEM supple-
mented with 10% FBS and penicillin–streptomycin. U2OS
DR-GFP, U2OS EJ5-GFP and U2OS SA-GFP reporter
stable cell lines were maintained in medium supplemented
with 1 g/ml puromycin. Rap80 knock out U2OS cells
were kindly provided by Dr. Daniel Durocher (Lunenfeld-
Tanenbaum Research Institute, Mount Sinai Hospital,
Toronto, Canada) and have been validated previously (24).
Cells were treated with camptothecin (CPT, 2 M), hy-
droxyurea (HU, 10 mM), ultra violet light (UV, 40 J/m2),
etoposide (ETP, 20 M) or ionizing radiation using a Cell-
Rad (Faxitron) or a WOMed superficial X-Ray Therapy
Unit and harvested 1 h later, unless stated otherwise.
siRNA oligos, plasmids and transfection
siRNA oligonucleotides (Sigma, Microsynth AG) were
transfected into cells using Lipofectamine RNAiMax (In-
vitrogen). Sequences of oligonucleotides were as follows:
Luc CGUACGCGGAAUACUUCGA
Non-Target UGGUUUACAUGUCGACUAA
PHF2#1 GCUGGAAAUUCGAGAGCAA
PHF2#2 GCUAGAGAAGUCGCCUCUA
PHF2#3 CCACUUUAAGGACAGCCUU
CtIP GCUAAAACAGGAACGAAUC
BRCA1 AAGGAACCUGUCUCCACAAAG
Plasmid DNA was transfected into cells using
Polyethylenimine (Sigma Aldrich) or Lipofectamine
2000 (Invitrogen).
p3FLAG murine PHF2 was kindly provided by Dr Xi-
aobing Shi (Department of Epigenetics andMolecular Car-
cinogenesis, The University of Texas M.D. Anderson Can-
cer Center, Houston, USA). Three silent mutations (in cap-
ital, gctggaGatCAgGgagcaa) were introduced in the Flag-
PHF2 plasmid) to make it resistant to siRNA oligonu-
cleotide PHF2#1 (Flag-PHF2*). A demethylase inactive
version of PHF2 containing the mutations H249A/D251A
(catalytic inactive, CI) and PHF2 PHD domain mutant
with W29E/H31A/C34A (PHDm) were generated in Flag-
PHF2*. For mutagenesis, the QuikChange Site-Directed
Mutagenesis Kit (Agilent Technologies) was used and mu-
tants were verified by Sanger-Sequencing. GFP-CtIP and
mCherry-NBS1 expressing plasmids have been previously
described (25,26).
Antibodies and western blot
Antibodies obtained from commercial sources were as fol-
lowing: -actin and Histone H3 from Genscript, Ku86
(C-20) and p53 (DO-1) from Santa Cruz Biotechnology,
53BP1 (Ab172580) and NBS1 (Ab175800) from Abcam,
pSer139-H2AX (clone: JWB301), BRCA1 (clone MS110)
from Merck-Millipore, pSer345-CHK1 and PHF2 from
Cell Signalling, PHF2 and pSer4/8-RPA2 from Bethyl,
RPA2 from Novus Biologicals, Rad51 by Invitrogen and
CtIP from Active Motif.
Also, antibodies against CtIP and Mre11 were generated
by injecting rabbits with a His-tagged antigen (amino acids
150–500 and 182–480, respectively) that were obtained by
expression in bacteria and purification with a Ni-NTA resin
(Qiagen) following manufacturers recommendations.
Cell were lysed in Laemmli sample buffer. Lysates con-
taining equal amounts of protein, measured by the BCA
method (Thermo Scientific), were subjected to SDS-PAGE.
The chemiluminescent images were obtained using the Im-
ageQuant LAS 4000 mini and quantified using the Image-
Quant TL software (GE Healthcare).
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Comet assay
Single Cell Gel Electrophoresis (SCGE) was carried out us-
ing the CometAssay® ES II kit (Trevigen) according to
the manufacturer’s instructions. Images were taken using a
Zeiss Cell Observer fluorescent microscope and the tail mo-
ment of at least 50 cells per experiment was analysed with
the TriTek CometScore software.
RT-PCR
RNA was isolated using the RiboZol Extraction Reagent
(VWR) according to the manufacturer’s instructions.
cDNA synthesis and PCR amplification were carried out
in the same tube using the qScript One-Step SYBR Green
RT-qPCR Kit (Quantabio) in a LightCycler480 II (Roche).
All reactions were performed in triplicate. Transcript levels
were normalized in parallel with test genes GAPDH. The
primers used were the following:
BRCA1-F: ACCTTGGAACTGTGAGAACTCT
BRCA1-R: TCTTGATCTCCCACACTGCAATA
CtIP-F: CAGGAACGAATCTTAGATGCACA
CtIP-R: GCCTGCTCTTAACCGATCTTCT
GAPDH-F: GGAGCGAGATCCCTCCAAAAT
GAPDH-R: GGCTGTTGTCATACTTCTCATGG
Mre11-F: ATGCAGTCAGAGGAAATGATACG
Mre11-R: CAGGCCGATCACCCATACAAT
RPA2-F: GCACCTTCTCAAGCCGAAAAG
RPA2-R: CCCCACAATAGTGACCTGTGAAA
DR-GFP, SA-GFP and EJ5-GFP assays
U2OS cells bearing a single copy integration of the reporters
DR-GFP (HR (27)), SA-GFP (SSA (28)) or EJ5-GFP
(NHEJ (28)) were used to analyse the different DSB repair
pathways. Cells were seeded in 6-well plates in duplicate and
transfected with the indicated siRNA oligonucleotide. The
next day, cells were infected with lentiviral particles con-
taining I-SceI–BFP expression construct at MOI 10 using
8 g/ml polybrene. Forty eight hours later, cells were col-
lected by trypsinization and fixed with 4% paraformalde-
hyde for 20 min. Samples were analysed with a BD FAC-
SAria with the BD FACSDiva Software.
The number of GFP-positive cells from at least 10 000
events positive for blue fluorescence (infected with the I-
SceI–BFP construct) was scored. The average of both du-
plicates was calculated for each sample and normalized
to siRNA control. At least three independent experiments
were carried out for each condition and the mean and stan-
dard deviation of the three experiments represented.
Chromatin fractionation
Biochemical fractionation of cells was performed as pre-
viously described (29,30). Soluble cytoplasmic and soluble
nuclear fractions were pooled to one soluble fraction.
Immunofluorescence
For immunostaining, cells were fixed in 4% paraformalde-
hyde for 15 min and then permeabilized with PBS + 0.2%
Triton X-100 for 10 min at RT. Samples were blocked in
PBS + 0.5% FCS, immunostained with antibodies as indi-
cated and mounted with DAPI. For RPA2, BRCA1 and
Rad51 focus formation, cells were pre-extracted (20 mM
HEPES pH 8, 20 mM NaCl, 5 mM MgCl2, 0.5% NP40)
for 5 min at 4◦C before fixation.
Images of cells were taken using a Zeiss Cell Observer flu-
orescent microscope equipped with a 63× NA 1.3 objective
and ZEN imaging software. The number of foci was evalu-
ated using the ImageJ software. In all instances, >100 cells
were analysed for each point and error bars on graphs rep-
resent the standard deviation of three independent experi-
ments. Cells with >10 foci were scored as positive.
Laser micro-irradiation
Multiphoton laser micro-irradiation was essentially per-
formed as described previously (31). Cells, grown on cov-
erslips, were placed in a Chamlide CMB magnetic cham-
ber and the regular culture medium was replaced by
CO2-independent Leibovitz’s L15 supplemented with 10%
FBS and penicillin-streptomycin. Laser micro-irradiation
was carried out on a Leica SP5 confocal microscope
equippedwith an environmental chamber set to 37◦C.DSB-
containing tracks (1.5 m width) were generated with a
Mira mode-locked titanium-sapphire (Ti:Sapphire) laser
( = 800 nm, pulse length = 200 fs, repetition rate = 76
MHz, output power = 80 mW) using a UV-transmitting
63× 1.4 NA oil immersion objective (HCX PL APO; Le-
ica). Confocal images were recorded before and after laser
irradiation at 5 or 10 s time intervals over a period of 5–10
min.
To examine accumulation of Flag-PHF2, a different field
was irradiated every minute for 20 min, after which the cells
were fixed for immunofluorescence.
FokI assays
U2OS 2-6-3 cells expressing inducible FokI-mCherry-LacR
(32) were treated with 300 nM 4-OHT and 1 M Shield-I
for 5 h for inducing stabilization and nuclear localization of
the expressed product. Subsequently, cells were fixed with
PFA and immunostained with the indicated antibodies as
described above.
Cell cycle analysis
For cell cycle analysis, cells were fixed in 70% ethanol at 4◦C
o/n. After fixation, cells were washed with PBS, and the
DNA was stained with propidium iodide (PI). Cells were
analysed using a Macsquant Analyzer with Macsquantify
software (Miltenyi).
Clonogenic survival
To determine cellular sensitivity to DNA damaging agents,
HeLa cells were transfected with the indicated siRNA
oligonucleotides. Forty eight hours later, 500 cells were
seeded in six-well dishes and treated with the indicated con-
centrations of Olaparib (Cayman Chemical) or doses of IR.
Following 7–10 days in culture, cells were fixed, stained and
colonies were counted. Triplicate cultures were scored for
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each treatment. Shown is the relative survival as compared
to the undamaged control and the error bars present the
standard error of three independent experiments.
Gene expression correlation analysis
Gene expression correlation analysis was performed us-
ing the Gene Expression Profiling Interactive Analysis
(GEPIA), a web-based tool containing high-throughput
RNA sequencing data (TCGA and GTEx databases) (33).
A pairwise gene correlation analysis for given tumour data
sets of TGCA was performed, with PHF2 as ‘gene A’ and
a correlation against ‘gene B’: RBBP8 (CtIP), BRCA1 or
GAPDH. All genes were normalized to TUBA1A (Tubu-
lin alpha-1A). The correlation coefficient was calculated
using Spearman rank correlation test against the tumour
dataset, which included a range different tumours of the fe-
male reproductive tract (cervical squamous cell carcinoma
and endocervical adenocarcinoma (CESC, n = 306), ovar-
ian serous cystadenocarcinoma (OV, n = 426), uterine cor-
pus endometrial carcinoma (UCEC, n = 174) and uterine
carcinosarcoma (UCS, n = 57)), and breast invasive carci-
noma (BRCA, n = 1085).
Statistical analysis and reproducibility
Gaussian (normal) distribution of the data was assessed us-
ing a D’ Agostino–Pearson omnibus normality test. In case
of normal distribution, an unpaired Student’s t-test was
used to determinewhether the difference between themeans
of two sets of values was significant. In case the distribution
was not normal, a Mann–Whitney test was used. *P < 0.1
**P< 0.01, ***P< 0.001, ****P< 0.0001. P< 0.05 was con-
sidered statistically significant. NS= not significant. Unless
stated otherwise, representative experiments are shown out
of at least two independent ones and depicted is the mean
± standard deviation. Additional details are listed in the in-
dividual figure legends.
RESULTS
The demethylase PHF2 controls the DNA damage response
To identify novel enzymes that regulate DSB repair by
NHEJ and HR, we analysed ionizing radiation (IR)-
induced focus formation of 53BP1 and BRCA1, that
together control the choice between these two DSB
repair pathways, in cells depleted for individual en-
zymes involved in post-translation modifications of hi-
stones by siRNA. Modulation of the expression level
of PHF2/KDM7C/JHDM1E, a lysine-specific histone
demethylase hereafter called PHF2, changed the dynamics
of 53BP1 focus formation in response to IR. Whereas irra-
diating U2OS cells triggered efficient 53BP1 focus forma-
tion, the number of cells with 53BP1 foci and the number
of 53BP1 foci per cell stayed high at later time points (4–
7 h) in cells depleted for PHF2 by siRNA whereas at these
time points 53BP1 foci decreased again in control trans-
fected populations (Figure 1A and Supplementary Figure
S1A). The effect of PHF2 depletion on 53BP1 focus res-
olution was the same as that of downregulation of CtIP,
which served as a control for negatively regulating HR by
preventing the initiation of DNA resection (Figure 1A).
In contrast, overexpression of Flag-PHF2 prevented IR-
induced focus formation of 53BP1 (Supplementary Figure
S1B). To examine the effect of modulating PHF2 levels on
HR, we monitored the recruitment of BRCA1 in Rap80
knock out U2OS cells, in which Rap80-mediated recruit-
ment of BRCA1, subsequent BRCA1-A complex forma-
tion and suppression of HR are prevented (31,34). Whereas
treating control siRNA transfected cells with IR led to effi-
cient focus formation of BRCA1 that increased in time, de-
pletion of PHF2 by siRNA impaired IR-induced BRCA1
foci (Figure 1B). The observed altered dynamics of BRCA1
and 53BP1 focus formation upon modulating the levels of
PHF2 suggests that this demethylase regulates DSB repair.
As a consequence, depletion of PHF2 led to increased fo-
cus formation of phosphorylated H2AX (H2AX), used as
marker for DNA damage, as compared to control-depleted
cells (Supplementary Figure S1C).
Depletion of PHF2 affects DSB resection and DNA repair
We continued to study what process in the DNA damage
response is affected by PHF2. To this end, we first exam-
ined DNA damage-induced checkpoint activation by ex-
posing U2OS cells to different types of DNA damage and
monitoring the phosphorylation of CHK1, a critical ef-
fector kinase of this response (35). Although DNA dam-
aging agents triggered efficient CHK1 phosphorylation in
control depleted cells, PHF2 depletion reduced the DNA
damage-induced phosphorylation of CHK1, especially af-
ter IR, camptothecin and etoposide (Figure 1C). These
treatments result in a more efficient DSB formation com-
pared to UV and HU, which only resulted in a moderate
effect, substantiating a possible role for PHF2 in the DSB
response. In addition, these treatments need DNA end re-
section to generate ssDNA, subsequently covered by the
RPA1–3 complex, that triggers the activation of ATR and
phosphorylation of its substrates such as CHK1 (36,37).
We therefore examined if PHF2 depletion affected DNA
end resection, by studying RPA2 phosphorylation using
western blot analysis (38). Downregulation of PHF2 led
to lower levels of RPA2 phosphorylation on Ser4/8 and
reduced levels of total RPA2 phosphorylation, as demon-
strated by a lower mobility shift using an antibody against
total RPA2, in response to camptothecin and etoposide, as
compared to control transfected cells (Figure 1D). To cor-
roborate these findings, we also measured IR-induced fo-
cus formation of RPA2 by immunofluorescence. As previ-
ously published, depletion of CtIP completely inhibited fo-
cus formation of RPA2 (Figure 1E). Notably, although less
pronounced when compared to that after CtIP knockdown,
the downregulation of PHF2 also significantly reduced IR-
induced focus formation of RPA (Figure 1E).
DSB resection is initiated by CtIP, together with the
MRN complex. Given the effect of PHF2 on DNA end re-
section, we wondered if PHF2 functions at the level of CtIP.
We consequently monitored the recruitment of GFP-CtIP
to DSB-containing tracks in U2OS cells by laser micro-
irradiation (25). An inhibition in the accumulation of GFP-
CtIP to the laser tracks was observed upon depletion of
PHF2, whereas the recruitment of mCherry-Nbs1, a com-
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Figure 1. PHF2 knockdown alters 53BP1 and BRCA1 focus dynamics in response to IR. (A) U2OS cells were depleted for Luciferase (Luc), CtIP or
PHF2 by siRNA. After 48 h, cells were treated with IR (10 Gy) and fixed after 1, 4 or 7 h. 53BP1 focus formation was analysed by immunofluorescence.
Left panel: representative images. Right panel: quantification of three independent experiments with each at least 100 cells. (B) U2OS Rap80 knockout
cells were depleted for Luc or PHF2. Cells were treated with IR (10 Gy), fixed at the indicated time points and H2AX (positive control for DNA damage
induction) and BRCA1 focus formation was analysed as in (A). Left panel: representative images (IR, 4 h). (C) U2OS cells depleted for Luc or PHF2 were
subjected to different DNA damaging agents and lysed after 1 h. Extracts were analysed by western blot using the indicated antibodies. (D) U2OS cells
were transfected as in (C), treated with CPT or ETP and analysed by western blot with the indicated antibodies. (E) U2OS cells were depleted for CtIP
or PHF2 by siRNA. Cells were treated with IR (3 Gy), fixed at the indicated time points and RPA2 focus formation was analysed as in (A). Left panel:
representative images (IR, 1 h).
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ponent of the MRN complex, was unaffected in these con-
ditions (Figure 2A). To investigate the consequences of the
effect of PHF2 onDNA end resection, we examined the IR-
induced accumulation of HR protein Rad51 on the chro-
matin. Downregulation of PHF2 prevented this accumula-
tion (Figure 2B). In accordance, when analysing Rad51 fo-
cus formation in response to IR by immunofluorescence, we
observed that knockdown of PHF2, as well as depletion of
CtIP, inhibited focus formation by Rad51 (Figure 2C). To-
gether these results indicate that PHF2 promotes the DSB
response by regulating DNA resection and strongly suggest
that the subsequent DSB repair is affected by PHF2 deple-
tion.
DNA end resection is a critical step in homology-directed
DSB repair (4). To address whether PHF2 impacts on
DSB repair by homologous recombination, we used a DR-
GFP reporter assay in U2OS. In these cells, depletion of
PHF2 caused a significant decrease in HR efficiency (Fig-
ure 2D). The efficiency of Single Strand Annealing (SSA),
another form of homology-directed repair that also de-
pends on CtIP-mediated DNA end resection but is Rad51-
independent (39), measured using an SA-GFP reporter as-
say, was also dramatically affected by PHF2 knockdown
(Supplementary Figure S1D). Surprisingly, depletion of
PHF2 also slightly inhibitedNHEJ, not dependent onDNA
end resection, as measured by the EJ5-GFP reporter (Sup-
plementary Figure S1E).
Cell cycle is a major determinant of DSB repair path-
way choice. As HR depends on the availability of a sister
chromatid as repair template, this type of repair is restricted
to the S and G2 phases of the cell cycle (40). Importantly,
PHF2 depletion only very slightly decreased the percentage
of cells in S phase, making it unlikely that the decrease in
DSB repair efficiency upon PHF2 knockdown is due to an
indirect effect on the cell cycle (Supplementary Figure S1F).
PHF2 controls CtIP and BRCA1 mRNA levels by means of
its demethylase activity
We next set out to address if PHF2 affects DSB repair in
a direct manner by acting at sites of DNA damage. To this
end, the accumulation of Flag-PHF2 at sites of DNA dam-
ages generated by laser micro-irradiation was examined. Al-
though mCherry-Nbs1 and H2AX were detected at dam-
aged regions upon laser micro-irradiation, we did not ob-
serve detectable Flag-PHF2 accumulation to such laser-
tracks (Supplementary Figure S2A). In addition, also no
accumulation of Flag-PHF2 was observed to a DSB cre-
ated in a single genomic locus containing an array of LacO
repeats following expression and tethering of an mCherry-
LacI-FokI nuclease fusion (Supplementary Figure S2B).
Together these results could be an indication that PHF2 reg-
ulates DSB repair in an indirect and more global manner.
Interestingly, PHF2 contains a zinc finger-like PHD
(plant homeodomain) finger, a motif found in proteins that
are involved in transcriptional regulation, possibly by recog-
nizing chromatin modifications (41), which led to the sug-
gestion that PHF2 might regulate DNA repair in a tran-
scriptional manner. Western blot analysis of the levels of
proteins involved in DSB repair demonstrated that down-
regulation of PHF2 led to diminished protein levels of CtIP
as well as BRCA1, while leaving Rad51, RPA2, 53BP1,
Nbs1 and Mre11 unaffected (Figure 3A). Downregulating
PHF2 by two additional siRNA oligonucleotides resulted
in the same phenotype as seen before, namely a diminished
abundance of CtIP andBRCA1 protein (Figure 3B). In con-
trast, overexpression of Flag-PHF2 had the opposite effect:
both BRCA1 and CtIP protein levels increased under these
conditions (Figure 3C). Furthermore, the lower protein lev-
els of BRCA1 and CtIP upon depletion of PHF2 were par-
tially rescued by expressing an siRNA-resistant version of
Flag-PHF2 (Figure 3D). In addition, we could comple-
ment the effects of PHF2 depletion on focus formation of
RPA2, Rad51 and 53BP1 by expressing siRNA-resistant
Flag-PHF2 (Figure 3E, F and Supplementary Figure S3A,
respectively). Together these data demonstrate that the ef-
fects of modulating PHF2 levels are genuinely due to the de-
pletion of PHF2 instead of an off-target effect of the siRNA
oligonucleotides used.
We next examined if PHF2 regulates CtIP and BRCA1 at
the transcriptional level by investigating the effect of PHF2
depletion on CtIP and BRCA1mRNA in U2OS by quanti-
tative PCR. The mRNA levels ofCtIP and BRCA1, but not
those ofMre11 andRPA2, were decreased under conditions
of PHF2 depletion when compared to control transfected
cells (Figure 4A), indicating that PHF2 controls homology-
directed DSB repair by regulating the mRNA levels of CtIP
and BRCA1, two proteins critical for DNA end-resection
and thereby initiation of HR.
As mentioned before, PHF2 harbours an N-terminal
PHD domain, a chromatin reader module, in addition to
the enzymatically active Jumonji-C (JmjC) domain (41).
To gain more insight into the mechanism of how PHF2
controls DSB repair, we investigated if the effect of PHF2
on DNA end resection depends on the lysine demethylase
activity and/or on the presence of a functional PHD do-
main. To do so, mutants of these domains were generated
by introducing changes in critical residues within these re-
gions in siRNA resistant Flag-PHF2 (42,43). These mu-
tants were subsequently expressed in PHF2-depleted cells
and IR-induced focus formation of RPA2 and Rad51 were
studied. The defect in RPA2 and Rad51 focus formation
caused by knockdown of PHF2 could be rescued by thewild
type (WT) and PHDmutant (PHDm) version of PHF2 but
not with catalytic inactive (CI) PHF2 (Figure 4B and C). In
accordance with these data, whereasWT and PHDmPHF2
could complement the decrease in BRCA1 andCtIP protein
levels caused by PHF2 depletion, expressing PHF2 CI did
not rescue the reduced BRCA1 and CtIP levels (Figure 4D).
Together these results demonstrate that the lysine demethy-
lase activity is required for the effect of PHF2 in resection.
In contrast, the PHD chromatin reader domain seems to be
dispensable.
PHF2 downregulation causes genome instability
As DNA repair is also important in unperturbed cells, de-
fective DSB repair caused by downregulation of PHF2 is
likely to affect genome stability and cell survival in these
conditions. Consistent with such a scenario, the colony
forming capacity of both U2OS and HeLa cells decreased
dramatically after depletion of PHF2 as compared to Lu-
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Figure 2. Depletion of PHF2 impairs DSB repair by homologous recombination. (A) U2OS cells, transfected with Luc or PHF2 siRNA oligos, and 24 h
later transfected with GFP-CtIP and mCherry-Nbs1, were laser-irradiated and analysed by time-lapse imaging. Upper panel: representative images of the
indicated time points. Lower panel: relative fluorescence (left: GFP-CtIP, right: mCherry-Nbs1) at laser stripes of at least 50 cells per experiment. (B) U2OS
cells were depleted for Luc or PHF2 by siRNA, treated with IR (10 Gy) and subjected to chromatin fractionation (WCE: whole cell extracts, Sol: soluble
and Chrom: chromatin). Samples were analysed by western blot using the indicated antibodies. (C) U2OS cells were depleted for Luc, CtIP or PHF2 by
siRNA. Cells were treated with IR (3 Gy), fixed after 4 h and Rad51 focus formation was analysed by immunofluorescence. Top panel: representative
images. Bottom panel: quantification from three independent experiments with each at least 100 cells. (D) U2OS cells stably expressing a single copy of
the DR-GFP reporter construct were depleted of CtIP, PHF2 or control (non-target, NT). After 48 h, GFP fluorescence was analysed by flow cytometry.
Presented is the relative fluorescence as compared to the control cells, of three independent experiments.
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Figure 3. PHF2 regulates HR by modulating CtIP and BRCA1 levels. (A) U2OS cells were depleted for Luc or PHF2 by siRNA. Forty eight hours later,
the cells were lysed and extracts were analysed by western blot with the indicated antibodies. (B) U2OS cells were depleted for PHF2 using three different
siRNA oligonucleotides and subsequently analysed by western blot using the indicated antibodies. (C) U2OS cells were transfected with empty vector (EV)
or a Flag-PHF2 expression vector, followed by western blot analysis with the indicated antibodies. (D) U2OS cells were depleted for Luc or PHF2 by siRNA
and 24 h later transfected with EV or siRNA-resistant Flag-PHF2 (Flag-PHF2*). The day after, extracts were prepared and analysed by western blot with
the indicated antibodies. (E) U2OS cells were depleted for PHF2 and transfected with Flag-PHF2* the day after. One day later, cells were treated with
IR (3 Gy) and fixed for IF after 1 h. RPA2 focus formation of Flag-positive cells was analysed by immunofluorescence. Top panel: representative images.
Bottom panel: quantification of three independent experiments, counting at least 50 cells each. (F) U2OS cells were depleted for PHF2 and transfected
with Flag-PHF2* the day after. One day later, cells were treated with IR (3 Gy) and fixed for IF after 4 h. Rad51 focus formation of Flag-positive cells was
analysed as in (E).
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Figure 4. PHF2 controls the expression of CtIP and BRCA1 through demethylase activity. (A) U2OS were downregulated with Luc or PHF2 siRNA
oligos. 72 h later, RNA was isolated and mRNA levels of GAPDH, RPA2, BRCA1, Mre11 and CtIP were determined by RT-qPCR. Shown is the fold
mRNA change of PHF2-depleted samples as compared to the Luc control. (B) U2OS cells were depleted for PHF2 and transfected with EV, siRNA
resistant Flag-PHF2 wild type (WT), demethylase inactive Flag-PHF2 (CI) or PHD domain mutant Flag-PHF2 (PHDm) the day after. One day later, cells
were treated with IR (5 Gy) and fixed for IF after 1 h. RPA2 focus formation of Flag-positive cells was analysed by immunofluorescence. Quantification
of three independent experiments with at least 50 cells each is shown. (C) U2OS cells were transfected as in (B). One day later, cells were treated with IR
(10 Gy) and fixed for IF after 4 h. Rad51 focus formation of Flag-positive cells was analysed by immunofluorescence. Quantification of three independent
experiments with at least 50 cells each. (D) U2OS cells were transfected as in (B) and the day after, extracts were prepared and analysed by western blot
with the indicated antibodies. Quantifications of BRCA1 and CtIP levels, compared to the loading control, are shown below each panel.
ciferase knockdown control cells (Figure 5A). Interestingly,
although downregulation of CtIP also affected clonogenic
survival, the effect was less severe than after PHF2 deple-
tion, suggesting that the effect of PHF2 on cell survival is
not solely due to its function in controllingHR (Supplemen-
tary Figure S3B).Western blot analysis demonstrated an in-
crease in H2AX in PHF2-depleted U2OS cells in the ab-
sence of exogenous damage (Figure 5B), and this was con-
firmed by an elevated percentage of cells with H2AX foci
upon PHF2 knockdown as compared to Luc control cells
by immunofluorescence (Figure 5C). To directly asses the
appearance of DNA breaks resulting from downregulation
of PHF2 in individual cells, we employed the alkaline comet
assay. Compared to control depleted cells, decreasing PHF2
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Figure 5. PHF2 controls genome stability. (A) U2OS andHeLa cells were depleted for PHF2 by siRNA. Equal numbers of cells were seeded and incubated
for 10 days for colonies to form. Bar graph shows the number of colonies compared to control depleted cells from three independent experiments. (B) U2OS
cells were depleted for Luc or PHF2 by siRNA. 48 h later the cells were lysed and analysed by western blot with the indicated antibodies. (C) As in (B), but
now H2AX focus formation was analysed by IF. Quantification of three independent experiments with each at least 100 cells. (D) U2OS cells, depleted
for PHF2 by siRNA, were left untreated or irradiated with 5 Gy and processed after 1 h for comet assay analysis. Depicted is the tail moment of three
independent experiments (at least 50 cells each). (E) Clonogenic survival assays of HeLa cells that were depleted for Luc, PHF2 or BRCA1 by siRNA and
incubated with the indicated concentrations of Olaparib. Shown is the relative survival as compared to the undamaged control. Error bars represent the
SEM of three individual experiments. (F) Correlation analysis between expression of PHF2 and expression of BRCA1, RBBP8 and GAPDH by GEPIA.
Scatter plots represent the correlation between gene expression of PHF2 and BRCA1 (left),RBBP8 (middle) orGAPDH (right) in each tumour (n= 2048),
with R as the correlation coefficient.
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by siRNA led to a significant tail moment increase in U2OS
and Hela cells, in the absence of exogenous DNA damage
as well as after IR (Figure 5D and Supplementary Figure
S3C). Together these data demonstrate that regulated lev-
els of PHF2 are important for the maintenance of genome
stability.
Notably, HR deficiency is exploited in the treatment
of tumours with BRCA1/BRCA2 mutations as cells in
such conditions are sensitive to inhibition of poly(ADP-
ribose) polymerase (PARP) (44). As PHF2 depletion affects
HR, downregulation of this protein is likewise expected
to result in sensitivity to PARP inhibition. Indeed, deple-
tion of PHF2 mildly sensitized HeLa cells to inhibition of
PARP1/2 by Olaparib (Figure 5E), which is in accordance
to its effect on BRCA1 levels. Co-depletion of PHF2 and
BRCA1 did not increase the sensitivity to PARP1/2 inhibi-
tion as compared to BRCA1 knockdown alone, suggesting
that the Olaparib sensitivity after PHF2 depletion is due to
its effect on BRCA1 (Supplementary Figure S3D). In ad-
dition, downregulation of PHF2 also caused sensitivity to
IR (Supplementary Figure S3E). Together these data un-
derscore the importance of PHF2 in HR.
Finally, we analysed the gene expression of PHF2,
BRCA1 and RBBP8, the gene encoding CtIP, in a broad
range of tumours of breast and the female reproductive
tract by GEPIA (33). As shown in Figure 5F, the expression
of PHF2 correlated with that of BRCA1 and RBBP8 in a
high proportion of the tumours (R ≥ 0.7), whereas the cor-
relation with GAPDH was lower (R= 0.55). These data are
in accordance with our previous experiments and strongly
suggest that the mechanism of regulation of BRCA1 and
CtIP expression by PHF2 also occurs in tumours.
DISCUSSION
In this study, we show that the demethylase PHF2 con-
tributes to the maintenance of genome integrity by con-
trolling DNA repair, predominantly through homology-
directed DSB repair. Specifically, we showed that downreg-
ulation of PHF2 affects the DNA damage-induced focus
formation by BRCA1 and 53BP1, which together determine
the choice between DSB repair by homologous recombina-
tion or non-homologous end joining. Concomitant with a
decrease in BRCA1 focus formation, PHF2 depletion also
affected the accumulation of CtIP to sites of DNA lesions.
CtIP is known to initiate DNA end resection to generate ss-
DNA ends that are a prerequisite for HR (10,25). BRCA1,
that forms a complex with CtIP, collaborates in ssDNA-end
formation (39,45,46). Indeed, impaired DSB resection was
observed after PHF2 downregulation, as demonstrated by
decreasedRPAphosphorylation and focus formation. Con-
sequently, PHF2 depletion compromised IR-induced focus
formation of Rad51 and resulted in a diminished efficiency
of HR. Impaired DSB repair by HR in response to PHF2
depletion is explained by our data showing that PHF2 con-
trols the DSB response by regulating CtIP and BRCA1
mRNA and protein levels. That PHF2 regulates expression
of CtIP and BRCA1 simultaneously is in accordance to in-
dications in the literature that BRCA1 supports the con-
trol of CtIP. CtIP was reported to control its own tran-
scription, possibly via interaction with BRCA1 through its
BRCT domains (47,48). BRCA1-dependent ubiquitination
of CtIP is additionally required for CtIP chromatin bind-
ing and damage-induced focus formation (49), which likely
explains the reported defect in the accumulation of GFP-
CtIP at interstrand crosslinks induced by micro-irradiation
(50). Our observation that depletion of PHF2 inhibits the
accumulation ofGFP-CtIP to the laser damage (Figure 2A)
is therefore likely to be an indirect effect of the diminished
BRCA1 levels in these conditions. However, we cannot ex-
clude the possibility that PHF2 regulates CtIP on several
levels, like the recently reported splicing complex SF3B, that
controls CtIP both at the level ofmRNAabundance and the
recruitment of CtIP to the chromatin in response to DNA
damage (51).
Interestingly, we also observed a modest decrease in the
efficiency of NHEJ after knockdown of PHF2. A possible
explanation for this result could be the decreased BRCA1
levels in these conditions, as depletion of BRCA1 has been
reported to affect NHEJ as well asHR (52,53). Depletion of
PHF2 also affected cell growth and led to genome instability
in unperturbed cells, as demonstrated by H2AX phospho-
rylation and comet assay analysis, an effect also recently re-
ported by others in mouse neural stem cells (54). Although
these results could be due to DNA repair defects, these ob-
servations might also reflect a separate phenotype of PHF2.
Indeed, PHF2 has been reported to be involved in the con-
trol of cell cycle regulation, cell differentiation and the in-
flammatory response (21,54,55).
The KDM7 family of histone demethylases, to which
PHF2 belongs, can remove the methylation from H3K9,
H3K27 orH4K20, which are responsible for transcriptional
repression, presumably by the concerted action of their
PHD methyl reader domain and the enzymatically active
JmjC-domain (41,56). Indeed, PHF2was described to regu-
late transcription by removing the dimethylated H3K9 and,
to a lesser extent, trimethylatedH4K20 (20–23).We hypoth-
esize that PHF2 controls CtIP and BRCA1 gene transcrip-
tion by erasing the transcription repression mark from the
respective promoters (23). PHF2 was shown to stimulate
the expression of genes driven by the transcription factors
HNF4, CEBP, p53 andNF-B (20–23). Interestingly,NF-
B was shown to regulate HR by controlling BRCA1-CtIP
complexes, although this effect is mediated by protein stabi-
lization of BRCA1 rather than by transcriptional regulation
of BRCA1 and CtIP (57).
The fact that a catalytic inactive version of PHF2 can-
not rescue the defect in DNA end resection and the lower
BRCA1/CtIP levels caused by PHF2 depletion suggests
that PHF2 controls the transcription of CtIP and BRCA1
mRNA by direct demethylation of H3K9me2 at the respec-
tive promotors. Interestingly however, although biochemi-
cal data indicate that PHF2 demethylates H3K9me2 upon
interaction with methylated H3K4 through its PHD do-
main (58), our experiments show that the PHD domain of
PHF2 is dispensable for its function on DSB resection and
control of BRCA1/CtIP levels. It is therefore possible that
PHF2 controls BRCA1/CtIPmRNA levels in another, pos-
sibly indirect way. Moreover, as dimethylation of H4K20 is
critical in the recruitment of 53BP1 to sites of DNA lesions
(59,60), interfering with this methyl mark and/or compe-
tition for binding to methylated H4K20 by PHF2 could
also contribute to the phenotype in disturbing homology-
directed DSB repair observed in this study.We consider this
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possibility less likely though, since at this moment, we have
no indications that PHF2might function directly at the sites
of DNA lesions.
By controlling DNADSB repair, PHF2 emerges as a pu-
tative important regulator inmaintaining genomic integrity.
Therefore, our data might have an importance in patholo-
gies in which PHF2 levels are changed or PHF2 is mutated.
For example, high PHF2 levels were found in oesophageal
carcinoma and renal cell carcinoma (61,62), whereas the
PHF2 gene is deleted or hypermethylated in its promoter re-
gion in breast cancer (63). In addition, PHF2 mutants were
reported in gastric and colon cancer (64). Together these
observations suggest that PHF2 plays a role in the develop-
ment and/or progression of cancer. Interestingly, the use of
histone demethylases as therapeutic targets by pharmaco-
logical inhibitors is currently being investigated and might
open new strategies for tumour therapy (65,66). Our results
demonstrating that depletion of PHF2 affects the sensitiv-
ity to inhibition of PARP, together with the observed corre-
lation between PHF2 and CtIP/BRCA1 levels in tumours,
might suggest that targeting PHF2 could be particularly ef-
fective in breast and ovarian cancers without mutations in
BRCA1/2 or other known HR proteins.
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